Skip to main content
. 2007 Jul 10;97(3):405–411. doi: 10.1038/sj.bjc.6603879

Table 1. Correlation between MK expression and clinicopathologic factors in pancreatic head carcinoma.

    MK expression
 
  Total n=75 Positive n=40 (53.3%) Negative n=35 (46.7%) P-values
Age (years)
 Mean±s.d.   67.4±8.9 64.9±9.9 0.2648
         
Gender
 Male 50 (66.7) 23 (57.5) 27 (77.1) 0.0718
 Female 25 (33.3) 17 (42.5) 8 (22.9)  
         
Histology
 Well 29 (38.7) 14 (35.0) 15 (42.9) 0.2318
 Moderately 43 (57.3) 23 (57.5) 20 (57.1)  
 Poor 3 (4.0) 3 (7.5) 0 (0.0)  
         
pT
 pT1 3 (4.0) 1 (2.5) 2 (5.7) 0.3699
 pT2 5 (6.7) 1 (2.5) 4 (11.4)  
 pT3 59 (78.7) 33 (82.5) 26 (74.3)  
 pT4 8 (10.7) 5 (12.5) 3 (8.6)  
         
pN        
 Negative 28 (37.3) 14 (35.0) 14 (40.0) 0.6552
 Positive 47 (62.7) 26 (65.0) 21 (60.0)  
         
Liver metastasis
 Negative 47 (62.7) 20 (50.0) 27 (77.1) 0.0153
 Positive 28 (37.3) 20 (50.0) 8 (22.9)  
         
pStage
 I 6 (8.0) 1 (2.5) 5 (14.3) 0.3651
 IIA 21 (28.0) 13 (32.5) 8 (22.9)  
 IIB 38 (50.7) 20 (50.0) 18 (51.4)  
 III 6 (8.0) 4 (10.0) 2 (5.7)  
 IV 4 (5.3) 2 (5.0) 2 (5.7)  
         
Lymphatic invasion
 Negative 9 (12.0) 4 (10.0) 5 (14.3) 0.5688
 Positive 66 (88.0) 36 (90.0) 30 (85.7)  
         
Venous invasion
 Negative 19 (25.3) 5 (12.5) 14 (40.0) 0.0063
 Positive 56 (74.7) 35 (87.5) 21 (60.0)  
         
Microvessel density
 Low grade 33 (44.0) 11 (27.5) 22 (62.9) 0.0021
 High grade 42 (56.0) 29 (72.5) 13 (37.1)  

MK=midkine; s.d.=standard deviation.